Imogas (Simeticone)

Simeticone reduces the surface tension of gas bubbles in the digestive tract, causing small bubbles to merge into larger ones. These larger bubbles are more easily expelled through belching or flatulence, which helps to alleviate the feeling of trapped gas and associated discomfort.

The appropriate dose of Imogas is determined by the prescribing clinician based on the patient’s age, weight, and the severity of symptoms. Dosage instructions are individualized and should be followed exactly as written on the prescription label.

The safety of simeticone in pregnancy and lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Imogas.

To order Imogas, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Imogas (simeticone) differs from activated charcoal or digestive enzymes because it works physically to coalesce gas bubbles rather than absorbing gas or altering digestion. This mechanism typically results in rapid symptom relief with a low incidence of systemic side effects.

Imogas should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme heat or humidity.

Imogas is taken orally. Depending on the formulation, the tablets or chewable tablets are swallowed whole with water or chewed as directed by the prescriber. Administration should follow the specific instructions provided on the prescription label.

While rare, serious risks include allergic reactions such as rash, urticaria, or anaphylaxis, and severe skin conditions like Stevens‑Johnson syndrome. Any signs of hypersensitivity should prompt immediate medical attention.

Individuals with a known hypersensitivity to simeticone or any of the product’s excipients should avoid using Imogas. It is also contraindicated in patients for whom the prescriber determines that the risks outweigh the benefits.